As a bioscience company, identifying your qualifying R&D activities and associated expenditure is easy isn't it? But is it just the discovery and 'blue sky' activities that qualify or are there in fact more activities carried on in the organisation that you haven't considered? If so, what might these be, how much could they be worth and how do you most efficiently identify them? Doubtless you will already have made R&D tax credits claims, but wouldn't you like to know whether you could have claimed significantly more? Deloitte has an experienced and award-winning team of R&D specialists who have helped bioscience clients to claim even more R&D tax relief than was at first sight available.

Bioscience companies do not always claim all their activities that could qualify under the R&D tax credits regime, often excluding significant areas of the business activities outside the research and discovery phases.

Are you confident that all the activities associated with bringing a product through to commercial production have been fully claimed?

For more information, download our brochure on R&D tax relief opportunities for companies in the bioscience sector (PDF, 68KB).